MDQK.HM MediNavi AG (HAM) up 200.00% to €7.50 on 26 Feb 2026: Monitor volume and liquidity
The MDQK.HM stock surged 200.00% intraday to €7.50 on 26 Feb 2026 during regular market hours on the HAM exchange in Germany. The move lifted the session high to €7.50 from an open of €2.50 and set a new year high. Volume remained thin at 35.00 shares versus an average of 41.00, which suggests the jump was amplified by low liquidity rather than broad institutional buying. We examine drivers, key ratios, technicals, and short-term trade ideas for MediNavi AG.
MDQK.HM stock: intraday surge and trading snapshot
MDQK.HM stock moved from a previous close of €2.50 to a session high of €7.50, a €5.00 increase equal to 200.00%. The reported session volume was 35.00 versus an average volume of 41.00, showing thin trading. Day range was €2.50–€7.50 and the year range now reads €1.50–€7.50.
MDQK.HM stock: likely drivers of the move
There is no public earnings release or formal earnings announcement linked to this spike. Given the low float and small reported volume, the jump is consistent with a liquidity-driven move, short-covering, or localized buyer interest. Traders should treat headlines and social chatter carefully until a confirmed corporate update appears.
Fundamentals, valuation and Meyka grade for MDQK.HM stock
MediNavi AG shows limited reported operating metrics: EPS and P/E are not available. Key ratios include a current ratio of 41.50, EV/EBITDA of 2.17, and return on equity near -6.60%. Enterprise value reads -255031.00 on the data feed, reflecting reporting gaps. Meyka AI rates MDQK.HM with a score out of 100: 62.66 | Grade B | Suggestion: HOLD. This grade factors in S&P 500 and sector comparisons, financial growth, key metrics, forecasts, analyst consensus, and other inputs. These grades are informational and not financial advice.
MDQK.HM stock: technicals and market context
Short-term technicals show averages well below current price: 50-day at €2.50 and 200-day at €2.00, highlighting a sharp gap up. Volatility indicators include an ATR of 5.00, and momentum measures are unreliable due to thin data. Healthcare sector performance YTD is 0.61%, so this isolated spike is not sector-driven.
MDQK.HM stock: risks and short-term catalysts
Key risks are lack of published EPS, unknown shares outstanding, near-zero reporting liquidity, and a market cap listed as 0.00 in the feed. Catalysts that could sustain the move include a formal corporate announcement, partnership news, or meaningful increases in trade volume. Absence of confirmation increases the probability of a reversal.
Trading approach for high-volume movers and monitoring MDQK.HM stock
With MDQK.HM stock showing thin liquidity, traders should use limit orders, tight position sizing, and pre-defined exit rules. Watch intraday volume against the 41.00 average and confirm any corporate release on the company site. For more real-time screening see Meyka’s stock page for MDQK.HM: MediNavi on Meyka.
Final Thoughts
MDQK.HM stock’s 200.00% intraday gain to €7.50 on 26 Feb 2026 is a clear example of a low-liquidity amplification event on the HAM exchange in Germany. Fundamentals are thin: EPS and P/E are unavailable, the reported market cap is 0.00, and working capital reads 269922.60, so valuation must be treated cautiously. Technicals show a large gap above the 50-day (€2.50) and 200-day (€2.00) averages, which raises the risk of a pullback without follow-through volume. Meyka AI’s forecast model projects a 12-month target of €5.20, implying a downside of -30.67% versus the current price €7.50; forecasts are model-based projections and not guarantees. Short-term traders should prioritise confirmed corporate news and volume confirmation, while longer-term investors should wait for audited financials and clear liquidity improvement before adding exposure.
FAQs
What caused the MDQK.HM stock spike today?
The spike appears driven by low liquidity and concentrated buying. No formal earnings or company announcement was present in public feeds. Thin volume (35.00 shares) versus an average of 41.00 suggests the move is liquidity-sensitive rather than broad institutional demand.
Should I buy MDQK.HM stock after the 200.00% move?
Caution is advised. Fundamentals are limited, EPS and P/E are unavailable, and market cap is reported as 0.00. Consider waiting for confirmed company updates and higher average volume before buying to reduce execution and reversal risk.
What is Meyka AI’s view on MDQK.HM stock performance?
Meyka AI rates MDQK.HM with a score out of 100 at 62.66 (Grade B, HOLD). The grade balances sector comparison, financial metrics, and forecasts. This rating is informational and not investment advice.
What key metrics should traders watch on MDQK.HM stock?
Watch intraday volume relative to 41.00 average, any corporate announcements, 50-day (€2.50) and 200-day (€2.00) averages, and volatility indicators like ATR (5.00). Confirm share count and market-cap updates before sizing positions.
Disclaimer:
Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.